Company / Gross Profit
Zomedica Corp. Gross Profit History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$21.7M
FY2025
5-year range
$13.5M / $21.7M
FY2022-FY2025
Trend
+13.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 3 consecutive years, from $13M in FY2022 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 3-year CAGR of +17.2%.
Improved from $17M to $22M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Zomedica Corp.'s gross profit has grown for 3 consecutive years.
- 3-year CAGR of +17.2%, indicating consistent growth.
- In FY2025, gross profit increased 13.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.7M | +13.6% |
| FY2024 | $19.1M | +10.2% |
| FY2023 | $17.3M | +28.6% |
| FY2022 | $13.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026